Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study. - Denys, P; Le Normand, L; Ghout, I (Eur Urol, 2012)